---
figid: PMC7160552__OR-43-06-1737-g02
figlink: pmc/articles/PMC7160552/figure/f3-or-43-06-1737/
number: F3
caption: Schematic diagram, introducing in detail the molecular mechanisms, clinical
  values and cell phenotypes affected by HOXA11-AS in different types of tumors, including
  (A) GC, (B) RC, (C) UM, (D) EOC, (E) LSCC, (F) CC, (G) ESCC, (H) osteosarcoma, (I)
  fracture, (J) PE and (K) DM. ‘Upregulation’/‘downregulation’ indicates that the
  expression level of HOXA11-AS in such a tumor was increased/decreased compared with
  normal tissues. The gray arrows (‘bind/sponge’) indicate that HOXA11-AS binds to
  the promoter region of a gene or, as a sponge, binds to a miRNA. The black arrows
  (‘Inf’) indicate that HOXA11-AS affects the phenotypes and the clinical characteristics
  of the cancer under consideration. The blue (‘Pro’) and green (‘In’) arrows indicate
  the promoting or inhibitory effects on the downstream genes, respectively. The purple
  arrows (‘Reg’) indicate the regulatory effects on the downstream pathway. GC, gastric
  cancer; RC, renal cancer; UM, uveal melanoma; EOC, epithelial ovarian cancer; LSCC,
  laryngeal squamous cell carcinoma; ESCC, esophageal squamous cell carcinoma; PE,
  pre-eclampsia; DM, diabetes mellitus; HOXA11-AS, HOXA11 antisense RNA.
pmcid: PMC7160552
papertitle: Recent advances in unraveling the molecular mechanisms and functions of
  HOXA11-AS in human cancers and other diseases.
reftext: Cheng Wei, et al. Oncol Rep. 2020 Jun;43(6):1737-1754.
pmc_ranked_result_index: '33348'
pathway_score: 0.7140205
filename: OR-43-06-1737-g02.jpg
figtitle: Recent advances in unraveling the molecular mechanisms and functions of
  HOXA11-AS in human cancers and other diseases
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7160552__OR-43-06-1737-g02.html
  '@type': Dataset
  description: Schematic diagram, introducing in detail the molecular mechanisms,
    clinical values and cell phenotypes affected by HOXA11-AS in different types of
    tumors, including (A) GC, (B) RC, (C) UM, (D) EOC, (E) LSCC, (F) CC, (G) ESCC,
    (H) osteosarcoma, (I) fracture, (J) PE and (K) DM. ‘Upregulation’/‘downregulation’
    indicates that the expression level of HOXA11-AS in such a tumor was increased/decreased
    compared with normal tissues. The gray arrows (‘bind/sponge’) indicate that HOXA11-AS
    binds to the promoter region of a gene or, as a sponge, binds to a miRNA. The
    black arrows (‘Inf’) indicate that HOXA11-AS affects the phenotypes and the clinical
    characteristics of the cancer under consideration. The blue (‘Pro’) and green
    (‘In’) arrows indicate the promoting or inhibitory effects on the downstream genes,
    respectively. The purple arrows (‘Reg’) indicate the regulatory effects on the
    downstream pathway. GC, gastric cancer; RC, renal cancer; UM, uveal melanoma;
    EOC, epithelial ovarian cancer; LSCC, laryngeal squamous cell carcinoma; ESCC,
    esophageal squamous cell carcinoma; PE, pre-eclampsia; DM, diabetes mellitus;
    HOXA11-AS, HOXA11 antisense RNA.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GC
  - EZH2
  - DNMT1
  - KDM1A
  - KLF2
  - PRSS8
  - CTNNB1
  - GIF
  - TENM1
  - NR4A3
  - MMP16
  - NODAL
  - RND3
  - Gastric cancer
  - tumor
  - Renal cancer
  - melanoma
  - Epithelial ovarian E Laryngeal squamous
  - carcinoma
  - cancer
  - aroplosis
  - Osteosarcoma
  - Diabetes mellitus
  - DM
  - Fracture
genes:
- word: (GC)
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: EZH2
  symbol: EZH2
  source: hgnc_symbol
  hgnc_symbol: EZH2
  entrez: '2146'
- word: DNMT1
  symbol: DNMT1
  source: hgnc_symbol
  hgnc_symbol: DNMT1
  entrez: '1786'
- word: EZH2
  symbol: EZH2
  source: hgnc_symbol
  hgnc_symbol: EZH2
  entrez: '2146'
- word: LSD1
  symbol: LSD1
  source: hgnc_alias_symbol
  hgnc_symbol: KDM1A
  entrez: '23028'
- word: EZH2
  symbol: EZH2
  source: hgnc_symbol
  hgnc_symbol: EZH2
  entrez: '2146'
- word: KLF2
  symbol: KLF2
  source: hgnc_symbol
  hgnc_symbol: KLF2
  entrez: '10365'
- word: KLF2
  symbol: KLF2
  source: hgnc_symbol
  hgnc_symbol: KLF2
  entrez: '10365'
- word: PRSS8
  symbol: PRSS8
  source: hgnc_symbol
  hgnc_symbol: PRSS8
  entrez: '5652'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: EZH2
  symbol: EZH2
  source: hgnc_symbol
  hgnc_symbol: EZH2
  entrez: '2146'
- word: KLF2
  symbol: KLF2
  source: hgnc_symbol
  hgnc_symbol: KLF2
  entrez: '10365'
- word: PRSS8
  symbol: PRSS8
  source: hgnc_symbol
  hgnc_symbol: PRSS8
  entrez: '5652'
- word: KLF2
  symbol: KLF2
  source: hgnc_symbol
  hgnc_symbol: KLF2
  entrez: '10365'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: TNM
  symbol: TNM
  source: hgnc_prev_symbol
  hgnc_symbol: TENM1
  entrez: '10178'
- word: minor
  symbol: MINOR
  source: hgnc_alias_symbol
  hgnc_symbol: NR4A3
  entrez: '8013'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: MMP-16
  symbol: MMP16
  source: hgnc_symbol
  hgnc_symbol: MMP16
  entrez: '4325'
- word: EZH2
  symbol: EZH2
  source: hgnc_symbol
  hgnc_symbol: EZH2
  entrez: '2146'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: nodal
  symbol: NODAL
  source: hgnc_symbol
  hgnc_symbol: NODAL
  entrez: '4838'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: RND3
  symbol: RND3
  source: hgnc_symbol
  hgnc_symbol: RND3
  entrez: '390'
- word: RND3
  symbol: RND3
  source: hgnc_symbol
  hgnc_symbol: RND3
  entrez: '390'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
- word: Inf
  symbol: INF
  source: hgnc_alias_symbol
  hgnc_symbol: GIF
  entrez: '2694'
chemicals: []
diseases:
- word: Gastric cancer
  source: MESH
  identifier: D013274
- word: tumor
  source: MESH
  identifier: D009369
- word: Renal cancer
  source: MESH
  identifier: D007680
- word: melanoma
  source: MESH
  identifier: D008545
- word: Epithelial ovarian E Laryngeal squamous
  source: MESH
  identifier: D000077216
- word: carcinoma
  source: MESH
  identifier: D002277
- word: cancer
  source: MESH
  identifier: D009369
- word: aroplosis
  source: ''
  identifier: ''
- word: Osteosarcoma
  source: MESH
  identifier: D012516
- word: Diabetes mellitus
  source: MESH
  identifier: D003920
- word: DM
  source: MESH
  identifier: D009223
- word: Fracture
  source: MESH
  identifier: D050723
figid_alias: PMC7160552__F3
redirect_from: /figures/PMC7160552__F3
figtype: Figure
---
